Jennie H. Best

Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies

Jennie H. Best, Byron J. Hoogwerf, William H. Herman et al. · Diabetes Care · 2010 · 252 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Patient perspectives on once‐weekly medications for diabetes

William H. Polonsky, Lawrence Fisher, Danielle Hessler et al. · Diabetes Obesity and Metabolism · 2010 · 128 citations

Pharmacy, Pharmacotherapy, Drug Information +16

Improved treatment satisfaction and weight‐related quality of life with exenatide once weekly or twice daily¹

Jennie H. Best, Kristina S. Boye, R. R. Rubin et al. · Diabetic Medicine · 2009 · 97 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +16

Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B‐cell lymphoma

John Hornberger, Jennie H. Best · Cancer · 2005 · 60 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +14

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

Sebastian Unizony, Timothy J. McCulley, Robert Spiera et al. · Arthritis Research & Therapy · 2021 · 60 citations · Full text

Life Sciences, Clinical Sciences, Pharmacotherapy +13